IP Library Granted Patent US 12,201,836
Granted Patent B2
US 12,201,836 · App. 17/342,186 · Granted Jan 21, 2025

Techniques for neuromodulation

Inventors: Christopher Michael Puleo (Niskayuna, NY); Jeffrey Michael Ashe (Gloversville, NY); Victoria Eugenia Cotero (Watervliet, NY); Michael Ernest Marino (Niskayuna, NY)
Assignee: GENERAL ELECTRIC COMPANY
A61N1/36071A61N1/3606A61N1/36121A61N1/36153A61N1/36171A61N2/006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,201,836
App. No.
17/342,186
Filed
Jun 8, 2021
Granted
Jan 21, 2025
Kind
B2
Art Unit
3792
USPC
607/2
Abstract

The subject matter of the present disclosure generally relates to techniques for neuromodulation of lymphatic tissue that include applying one or more energy pulses to a neuron of a subject, e.g., via an electrode positioned to deliver sufficient energy to the neuron, to modulate immune function. For example, an adaptive immune reflex of a subject may be modulated via neuromodulation.

Claims (24)

1. A method of neuromodulation, comprising:

applying one or more energy pulses to a neuron of a subject to deliver sufficient energy to the neuron to neurally modulate a lymphatic tissue in response to applying the one or more energy pulses;

acquiring image data of the lymphatic tissue using an ultrasound imaging probe; and

changing modulation parameters of the one or more energy pulses based on the image data.

2. The method of claim 1 , wherein the lymphatic tissue is a lymph node.

3. The method of claim 1 , wherein the neuron is a parasympathetic or sympathetic neuron innervating a primary, secondary, or tertiary lymphatic tissue structure or communicating tissue.

4. The method of claim 1 , wherein the subject has a diagnosis of an autoimmune disorder.

5. The method of claim 1 , wherein acquiring the image data comprising acquiring baseline image data and post-modulation image data.

6. The method of claim 5 , wherein the post-modulation image data is acquired within 30 minutes of applying the one or more energy pulses.

7. The method of claim 1 , wherein changing the modulation parameters comprises decreasing or stepping back energy levels of the one or more energy pulses.

8. The method of claim 1 , wherein the image data is indicative of an increase in size of the lymphatic tissue above a threshold, wherein the increase in size is indicative of successful modulation.

9. The method of claim 1 , wherein the increase in size is an increase in volume of the lymphatic tissue.

10. The method of claim 1 , wherein the image data is indicative of a lack of change in size of the lymphatic tissue relative to a threshold, and wherein a controller is configured to increase the modulation parameters based on the lack of change in size.

11. The method of claim 1 , wherein applying the one or more energy pulses causes the lymphatic tissue to increase in size, wherein the lymphatic tissue is a lymph node, and wherein the increase in size of the lymph node is associated with a decrease in lymphocyte egress from the lymph node.

12. A system for neuromodulation of lymphatic tissue, comprising:

an energy application device configured to apply one or more energy pulses to a neuron of a subject to deliver sufficient energy to the neuron to neurally modulate a lymphatic tissue in response to applying the one or more energy pulses;

a noninvasive ultrasound imaging probe configured to acquire image data of the lymphatic tissue before and after neurally modulating the lymphatic tissue; and

a controller configured to:

cause the energy application device to generate the one or more energy pulses according to modulation parameters;

identify a change in size of the lymphatic tissue caused by applying the one or more energy pulses based on the image data; and

change the modulation parameters based on the identified change in size of the lymphatic tissue.

13. The system of claim 12 , wherein the lymphatic tissue is a lymph node.

14. The system of claim 12 , wherein the subject has a diagnosis of an autoimmune disorder.

15. The system of claim 12 , wherein the change in size is relative to a baseline size determined from the image data acquired before neurally modulating the lymphatic tissue.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded May 8, 2025
From: GENERAL ELECTRIC COMPANY
To: GE PRECISION HEALTHCARE LLC
Reel/Frame 071225/0218 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2021
From: PULEO, CHRISTOPHER MICHAEL; ASHE, JEFFREY MICHAEL; COTERO, VICTORIA EUGENIA; MARINO, MICHAEL ERNEST
To: GENERAL ELECTRIC COMPANY
Reel/Frame 056472/0838 →
Continuity (4)
Continuation 16091486
Provisional Application 62325828 · Apr 21, 2016
Provisional Application 62318035 · Apr 4, 2016
Related Publication 20210299449A1 · Sep 30, 2021
References Cited (65)
US 5305745A · Zacouto · 1994 [cited by applicant]
US 5391143A · Kensey · 1995 [cited by applicant]
US 6038478A · Yuen et al. · 2000 [cited by applicant]
US 6115637A · Lennox et al. · 2000 [cited by applicant]
US 6721603B2 · Zabara et al. · 2004 [cited by applicant]
US 6901296B1 · Whitehurst et al. · 2005 [cited by applicant]
US 6970741B1 · Whitehurst et al. · 2005 [cited by applicant]
US 7418292B2 · Shafer · 2008 [cited by applicant]
US 7526337B2 · Shuros et al. · 2009 [cited by applicant]
US 7894906B2 · Shuros · 2011 [cited by applicant]
US 7904162B2 · Whitehurst et al. · 2011 [cited by applicant]
US 8321012B2 · Della Rocca et al. · 2012 [cited by applicant]
US 9108057B2 · Rezai et al. · 2015 [cited by applicant]
US 9211409B2 · Tracey et al. · 2015 [cited by applicant]
US 20030036773A1 · Whitehurst et al. · 2003 [cited by applicant]
US 20030113303A1 · Schwartz · 2003 [cited by applicant]
US 20040158297A1 · Gonzalez · 2004 [cited by applicant]
US 20050075701A1 · Shafer · 2005 [cited by applicant]
US 20050075702A1 · Shafer · 2005 [cited by applicant]
US 20050143787A1 · Boveja et al. · 2005 [cited by applicant]
US 20060111754A1 · Rezai et al. · 2006 [cited by applicant]
US 20070027484A1 · Guzman et al. · 2007 [cited by applicant]
US 20070049514A1 · Morgan · 2007 [cited by applicant]
US 20070156179A1 · S.E. · 2007 [cited by applicant]
US 20070244520A1 · Ferren et al. · 2007 [cited by applicant]
US 20070282376A1 · Shuros et al. · 2007 [cited by applicant]
US 20070282380A1 · Brooke et al. · 2007 [cited by applicant]
US 20070282382A1 · Shuros et al. · 2007 [cited by applicant]
US 20070282386A1 · Shuros · 2007 [cited by applicant]
US 20070282390A1 · Shuros · 2007 [cited by applicant]
US 20080009719A1 · Shuros et al. · 2008 [cited by applicant]
US 20080021503A1 · Whitehurst et al. · 2008 [cited by applicant]
US 20080097412A1 · Shuros et al. · 2008 [cited by applicant]
US 20080215101A1 · Rezai et al. · 2008 [cited by applicant]
US 20080294228A1 · Brooke et al. · 2008 [cited by applicant]
US 20090247934A1 · Tracey et al. · 2009 [cited by applicant]
US 20100042170A1 · Shuros et al. · 2010 [cited by applicant]
US 20100228310A1 · Shuros et al. · 2010 [cited by applicant]
US 20100256700A1 · Shuros et al. · 2010 [cited by applicant]
US 20110028859A1 · Chian · 2011 [cited by applicant]
US 20110029037A1 · Rezai et al. · 2011 [cited by applicant]
US 20110150924A1 · Della Rocca et al. · 2011 [cited by applicant]
US 20110152967A1 · Simon et al. · 2011 [cited by applicant]
US 20110152974A1 · Rezai et al. · 2011 [cited by applicant]
US 20110178441A1 · Tyler · 2011 [cited by examiner]
US 20120310140A1 · Kramer et al. · 2012 [cited by applicant]
US 20130178829A1 · Rezai et al. · 2013 [cited by applicant]
US 20130324892A1 · Zhu et al. · 2013 [cited by applicant]
US 20150025422A1 · Tyler · 2015 [cited by applicant]
US 20150080926A1 · Emery · 2015 [cited by examiner]
US 20150111918A1 · Sobotka et al. · 2015 [cited by applicant]
US 20150224348A1 · Iyer et al. · 2015 [cited by applicant]
US 20160022976A1 · Peyman · 2016 [cited by examiner]
US 20160067491A1 · Rezai et al. · 2016 [cited by applicant]
US 20160096016A1 · Tracey et al. · 2016 [cited by applicant]
US 20160279021A1 · Hyde et al. · 2016 [cited by applicant]
US 20190038898A1 · Chavan et al. · 2019 [cited by applicant]
WO 2006007048A2 · 2006 [cited by applicant]
Giglioiti. el al ‘Ultrasound Prevents Renal Ischemia,Reperfusion Injury By Stimulating the Splenic Cholinergic Anti-Inflammatory Pathway’. Jasn. Sep. 2013, Z,T, pp. 1340-1342, Published Ahead of Print Aug. 1, 2013, ISSN… [cited by applicant]
International Search Report and Written Opinion for corresponding PCT application No. PCT/US2017/025971 with a mail date of Jun. 22, 2017; 11 pages. [cited by applicant]
Rosas-Ballina et al., The Neurology of the Immune System: Neural Reflexes Regulate Immunity, Neuron, Oct. 15, 2009, vol. 64, Issue: 1, pp. 28-32. [cited by applicant]
Schroeppel et al., Direct current ablation destroys multi-stage fibrosarcomas in rats, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Sep. 3-6, 2009, pp. 3099-3104, Confere… [cited by applicant]
Straub et al., Neuronally released sympathetic neurotransmitters stimulate splenic interferon-γ secretion from T cells in early type II collagen-induced arthritis, Arthritis & Rheumatism, Nov. 2008, vol. 58, Issue: 11, … [cited by applicant]
Ugalde et al., Model-based design of control modules for neuromodulation devices, 2015 7th International IEEE/EMBS Conference on Neural Engineering (NER), Apr. 22-24, 2015, pp. 462-465 Conference Location: Montpellier. [cited by applicant]
Chinese Office Action for CN Application No. 201780020897.6 mailed Dec. 3, 2021, 11 pgs. [cited by applicant]